z-logo
open-access-imgOpen Access
Efficacy and safety of ultra-low dose inhaled melphalan in the treatment of hospitalized patients with COVID-19
Author(s) -
E. A. Sinitsyn,
Alexandra Zykova,
R. V. Shamin,
А. В. Рвачева,
A. O. Bogatyreva,
T. V. Shapovalenko,
G. G. Maryin,
К. А. Зыков
Publication year - 2022
Publication title -
acta biomedica scientifica (east siberian biomedical journal)
Language(s) - English
Resource type - Journals
eISSN - 2587-9596
pISSN - 2541-9420
DOI - 10.29413/abs.2022-7.2.2
Subject(s) - melphalan , medicine , inhalation , adverse effect , clinical trial , covid-19 , anesthesia , multiple myeloma , disease , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom